In last trading session, Milestone Pharmaceuticals Inc (NASDAQ:MIST) saw 0.99 million shares changing hands with its beta currently measuring 0.81. Company’s recent per share price level of $1.17 trading at -$0.02 or -1.68% at ring of the bell on the day assigns it a market valuation of $62.55M. That closing price of MIST’s stock is at a discount of -135.04% from its 52-week high price of $2.75 and is indicating a premium of 46.15% from its 52-week low price of $0.63. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.13 million shares which gives us an average trading volume of 2.60 million if we extend that period to 3-months.
For Milestone Pharmaceuticals Inc (MIST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Upright in the red during last session for losing -1.68%, in the last five days MIST remained trading in the red while hitting it’s week-highest on Thursday, 05/08/25 when the stock touched $1.17 price level, adding 11.36% to its value on the day. Milestone Pharmaceuticals Inc’s shares saw a change of -50.42% in year-to-date performance and have moved -9.30% in past 5-day. Milestone Pharmaceuticals Inc (NASDAQ:MIST) showed a performance of 40.69% in past 30-days. Number of shares sold short was 2.37 million shares which calculate 1.11 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 88.3% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -754.7% in reaching the projected high whereas dropping to the targeted low would mean a loss of -754.7% for stock’s current value.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 28.21% during past 5 years.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Insiders are in possession of 0.65% of company’s total shares while institution are holding 33.28 percent of that, with stock having share float percentage of 33.50%. Investors also watch the number of corporate investors in a company very closely, which is 33.28% institutions for Milestone Pharmaceuticals Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at MIST for having 4.97 million shares of worth $6.56 million. And as of 2024-06-30, it was holding 7.5135 of the company’s outstanding shares.
The second largest institutional holder is RTW INVESTMENTS, LP, which was holding about 3.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.9211 of outstanding shares, having a total worth of $4.3 million.
On the other hand, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund and SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 19.87 shares of worth $23250.0 or 0.04% of the total outstanding shares. The later fund manager was in possession of 18.54 shares on Mar 31, 2025 , making its stake of worth around $21688.0 in the company or a holder of 0.03% of company’s stock.
